FETAL CELL TISSUE, IN VACCINES have FETAL CELL TISSUE.
Mandated by the US Government.
4.1.14 Human Fetal Tissue Research - National Institutes of Health
4.1.14 Human Fetal Tissue Research. Human fetal tissue is defined as tissue or cells obtained from a dead human embryo or fetus after a spontaneous or induced abortion or stillbirth. This definition does not include established human fetal cell lines. Sections 498A and 498B of the PHS Act (42 U.S.C. 289g-1 and 289g-2) set forth specific
https://grants.nih.gov/grants/policy/nihgps/HTML5/section_4/4.1.14_human_fetal_tissue_research.htm
https://www.patheos.com/blogs/hedgerow/2020/07/groups-lists-products-for-which-aborted-baby-tissue-is-used-for-testing-vaccine-information/
HEK 293T cells & WI-38 & MRC5 Fetal Tissue in Vaccines:
Coreill Selling Human Aborted Fetal mTissue:
https://coriell.org/0/Sections/Search/Sample_Detail.aspx?Ref=AG05965-C
Regeneron & Aborted Human Fetal Stem Cells:
https://nypost.com/2020/10/08/regeneron-covid-19-treatment-tested-using-aborted-fetal-tissue-cells/
PBS just puts it right out there unafraid and unashamed:
https://www.pbs.org/newshour/health/medical-researchers-say-fetal-tissue-remains-essential
Republican Oversight Committee:
More Govt. Testimony:
CDC ADMISSION:
https://www.cdc.gov/vaccines/pubs/pinkbook/downloads/appendices/b/excipient-table-2.pdf
Christian Post Article:
Catholic News Agency Article:
The Federalist Article:
BoomLive Article:
https://www.boomlive.in/health/explained-use-of-aborted-fetal-cells-in-vaccine-production-10713
This is the stateās playbook on how to handle anything that erodes trust in the shots. It even has guides on what to say. Every public statement by a journalist/politician is scripted by the WHO.
ABSTRACT
This manual was developed to support countries in effectively responding to events which may erode the publicās trust in vaccines and the authorities that deliver them. In addition, a small section of this manual focuses on how to best prepare for a potential crisis and provides some insights into conducting post-crisis assessments. For the response phase, step-by-step guidance is provided on how to manage the communication aspects of a vaccine crisis.
https://apps.who.int/iris/bitstream/handle/10665/352029/WHO-EURO-2022-3471-43230-60590-eng.pdf?sequence=1